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Abstract
Background: Pakistan is the sixth most populous nation in the world and has an estimated 4 million stroke survivors. Most
survivors are taken care of by community-based caregivers, and there are no inpatient rehabilitation facilities.
Objective: The objective of this study was to evaluate the effectiveness and safety of locally designed 5-min movies rolled out
in order of relevance that are thematically delivered in a 3-month program to deliver poststroke education to stroke survivor and
caregiver dyads returning to the community.
Methods: This study was a randomized controlled, outcome assessor–blinded, parallel group, single-center superiority trial in
which participants (stroke survivor-caregiver dyads) with first-ever stroke (both ischemic and hemorrhagic) incidence were
randomized within 48 hours of their stroke into either the video-based education intervention group or the control group. The
video-based education intervention group had health education delivered through short videos that were shown to the participants
and their caregivers at the time of admission, before discharge, and the first and third months of follow-up after discharge. The
control group had standardized care including predischarge education and counseling according to defined protocols. All participants
enrolled in the video education intervention and control groups were followed for 12 months after discharge for outcome assessment
in the outpatient stroke clinics. The primary outcome measures were the proportion of participants achieving control of blood
pressure, blood sugar, and blood cholesterol in the video intervention versus the control group. Several predefined secondary
outcomes were included in this study, of which we report the mortality and functional disability in this paper. Analysis was by
performed using the intention-to-treat principle.
Results: A total of 310 stroke survivors and their caregiver dyads (participant dyads) were recruited over a duration of 6 months.
In total, 155 participant dyads were randomized into the intervention and control groups, each. The primary outcome of control
of three major risk factors revealed that at 12 months, there was a greater percentage of participants with a systolic BP<125 mm
Hg (18/54, 33% vs 11/52, 21%; P=.16), diastolic BP<85 mm Hg (44/54, 81% vs 37/52, 71%; P=.21), HbA1c level<7% (36/55,
65% vs 30/40, 75%; P=.32), and low-density lipoprotein level<100 mg/dL (36/51, 70% vs 30/45, 67%; P=.68) in the intervention
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group than in the control group. The secondary outcome reported is the mortality among the stroke survivors because the number
of stroke-related complications was higher in the control group than in the intervention group (13/155, 8.4% vs 2/155, 1.3%),
and this difference was statistically significant (P<.001).
Conclusions: The Movies4Stroke trial failed to achieve its primary specified outcome. However, secondary outcomes that
directly related to survival skills of stroke survivors demonstrated the effectiveness of the video-based intervention on improving
stroke-related mortality and survival without disability.
Trial Registration: ClinicalTrials.gov NCT02202330; https://www.clinicaltrials.gov/ct2/show/NCT02202330
(JMIR Mhealth Uhealth 2020;8(1):e12113)  doi: 10.2196/12113
KEYWORDS
stroke; mobile health; noncommunicable diseases; adherence
Introduction
Background
Stroke is the second leading cause of death globally and the
principal cause of acquired disability in adults. About two-thirds
of this burden is endured by the developing world [1].
Noncommunicable diseases (NCDs) are the biggest contributors
to the rising incidence of stroke. Around 90.5% of the global
stroke burden is attributable to modifiable risk factors, including
74.2% attributed to behavioral factors (smoking, poor diet, and
low physical activity). In addition, hypertension, type 2 diabetes
mellitus, and coronary artery disease are important modifiable
risk factors for stroke [2]. Pakistan also has a disproportionate
burden of stroke and NCD risk factors. At present, around 1 in
4 adult Pakistanis has hypertension or diabetes, heart disease,
or a stroke equivalent, with most being unaware of their risks
[3]. A local study investigated the prevalence of stroke in
Pakistan among adult Pashtun population and reported a
prevalence of 4.8%, which is equal to 4 million persons affected
in a country with a population of 180 million [3].
Studies that describe the outcomes of stroke survivors in this
setting report that at a median of 5.5 months after discharge,
12.3% of the patients had died, mostly from recurrent vascular
events or stroke complications. Poor functional outcome, defined
as Modified Rankin Scale (mRS) score>2, was seen in 51% of
the study participants, and cognitive outcomes were poor in
42% of the survivors [4].
In a country of a population of 180 million, roughly only 23
centers exist to provide physical medicine or help with
rehabilitation; most have not adopted a multidisciplinary
approach toward patients, and none have inpatient services [5].
Currently, there are no organized home care survival programs
involving primary caretakers for stroke survivors in Pakistan.
Despite these challenges, there is potential to leverage mobile
technology to improve stroke outcomes. Pakistan has widespread
mobile connectivity, with a cellular density of 77% [6]. These
infrastructure enablers create distinct opportunities for mobile
health (mHealth). Our rationale was to leverage information
technology (IT)–based mHealth to provide a solution and
knowledge and direct skills to the survivor and caregiver where
the provision of chronic care is rudimentary.
Objective
In this study, we aimed to evaluate the effectiveness and safety
of locally designed 5-min movies rolled out in order of relevance
that are thematically delivered in a 3-month program to deliver
poststroke education to stroke survivor and caregiver dyads
returning to the community. We hypothesized that the absence
of trained personnel in the health community could be mitigated
by actually providing high-quality repetitive training using audio
visual aids that served as a checklist for competency and survival
skills to the stroke survivor and caregiver dyad [7,8].
Methods
Study Design
A randomized controlled, outcome assessor–blinded, parallel
group, single-center superiority trial was conducted to assess
the efficacy of mobile phone video–based IT intervention for
controlling 3 major risk factors–blood pressure [BP], blood
glucose, and cholesterol—among adult stroke survivors.
Important secondary outcomes included postdischarge mortality
attributable to stroke and measures of functional disability. Our
detailed protocol has been published separately [9].
Study Site
This trial was conducted in the Stroke unit, Neurology Ward,
Aga Khan University Hospital (AKUH), Karachi, Pakistan.
AKUH is an internationally recognized tertiary care institution,
certified by Joint Commission International Accreditation, and
caters to the needs of a large multiethnic urban population of
18 million people. Stroke care follows international protocols,
with defined order sets and standardized pathways.
Participants
The sample population comprised adults (aged>18 years)
admitted to AKUH with first-ever acute stroke and having a
designated caregiver, meeting the eligibility criteria, and giving
informed consent.
The criteria used while recruiting participants and caregivers at
the initial phase of the selection process are listed below.
Eligibility Criteria
The eligibility criteria have been presented in Textboxes 1 and
2.
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Textbox 1. Inclusion criteria.
• Adult men and women aged ≥18 years of age
• Residents of Karachi and planning to live in Karachi till the follow-up period
• Able to understand Urdu (language of the videos) and the national language
• Admitted with first-ever stroke (ischemic or hemorrhagic)
• Modified Rankin Scale score≤4 (mild to moderate disability)
• Having at least one vascular risk factor that requires medical intervention
• Consenting to participate in the study and for follow-up visits, both stroke survivor and caregiver
• Have a designated caregiver at home who is responsible for appointments, follow-up, and overall care and are mobile phone literate, for example,
wife, daughters, daughter-in-law, and husband
• Stroke was medically stable, and participant was likely to return to the community after the in-hospital stay (thus actively treated strokes such
as decompressive surgeries, carotid endarterectomy, in-hospital sepsis, and ventilator complications that essentially preclude return to the
community settings were not offered in this chronic care support study).
Textbox 2. Exclusion criteria.
• Serious aphasia, visual hemineglect, short-term memory loss in the stroke survivor precluding understanding, visualization, or retention of the
video material.
• Serious aphasia, visual hemineglect, short-term memory loss, dementia in the caregiver precluding understanding, visualization, or retention of
the video material.
• Iatrogenic stroke, that is, stroke due to nonatherosclerotic vascular disease and rare causes, for example, carotid dissections, gunshot to neck,
and coronary artery bypass surgery
• Stroke survivor/caregiver dyad continued poststroke care in a nursing-assisted, professional, or hospital setting and does not return to the community
after discharge
• Serious concurrent medical illnesses such as cancer, renal failure, acute liver disease in past 6 months (that precludes use of statins), and chronic
liver disease, which that exclude the use of stroke preventive medications or require nonstandardized therapy
• Any use of off-label, nonguideline medications, because of the stroke survivors’ unique comorbidities, that interferes with medication compliance
to antihypertensive, statins, antiplatelet, and antidiabetic agents
Randomization Process
Stroke survivors and their caregivers (dyad) were assigned to
either the intervention or the usual care (control) groups in a
parallel manner in a ratio of 1:1. Block randomization technique
with a fixed block size of 10 was used. A computer-generated
randomization list was used to randomize participants into the
intervention or control group. The randomization center was
performed in a secure computer in the clinical trials unit (CTU),
and the randomization list was generated by CTU staff not
involved in recruitment, outcome ascertainment, or any aspect
of the study.
Allocation Concealment
The randomization list was centralized and thus not predictable.
No one from the research team had any access to randomization
list, randomization envelopes, and block size or code. Envelopes
were sealed and opaque, and it was impossible to view the
sequence even if held against bright sunlight. Randomization
list and opaque envelopes containing the randomization
sequence were always kept inside the premises of CTU under
lock and key.
Identification and Enrollment of the Study Participants
Informed consent was obtained from eligible participants who
volunteered to be a part of this study after they were provided
a thorough explanation regarding the nature of the study and
the scheduled follow-up visits. A detailed face-to-face interview
of stroke survivors and their caregivers was conducted to gather
data on sociodemographic and medical history. A baseline
clinical and functional assessment was performed, after which
they were randomly assigned into the intervention or control
group by a trained research officer who was not blinded to the
assignment of the intervention. Details regarding the proper
functioning of mobile app and its installation were taught to the
participants in the intervention group. A memory card containing
Movies4Stroke app was installed in the participant’s Android
phone along with the delivery of the first set of 5-min videos.
Videos were shown at the time of enrollment into the study, at
discharge, and at the first and third month after discharge from
the hospital. The app was designed to provide access to the
videos in a scheduled manner. To maintain contact and
follow-up, a Stroke Helpline number was provided to
participants in both the groups. The helpline number was active
24/7, and the person operating at the helpline number was
trained to receive calls with the most frequently anticipated
questions and to answer them accordingly. The operator had
access to a stroke specialist at all times for support. If the
participant was allocated to the usual care group, he/she was
informed about the details regarding discharge, follow-up
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appointments at the clinic, and access to free lab vouchers at
the 6th and 12th months.
Sampling Technique
A purposive sample was selected from adult stroke survivors
admitted into the Stroke unit, Neurology Ward, AKUH, Karachi,
after the assessment of the eligibility criteria and obtaining
informed consent.
Technical Part of the Intervention
The Movies4Stroke app was developed by biomedical and
software engineers of Aga Khan Development Network
Electronic Health (eHealth) Resource Center in collaboration
with stroke specialists, rehabilitation and swallowing experts,
and epidemiologists. The intervention was first pilot tested on
study team members’ Android cell phones. Any discrepancies
and bugs were removed from the app. The intervention was
then launched on tablets, specially purchased for showing
movies to the stroke survivors and their caregivers in clinical
ward settings. Memory chips were also purchased, so that the
Movies4Stroke app could be transferred into the participants’
cell phones.
Participants in the intervention group were sent weekly messages
twice as a reminder to watch the movies at home. These
messages were sent through a Web-based, programmed,
open-access software entitled Frontline by a trained IT
professional.
Intervention Group
In addition to the usual care, the intervention group at the time
of admission received the introductory teaching session with
installation of the app and the first set of 5-min videos on various
stroke-related topics as described below. In the first session,
different skills such as swallowing exercises, different
rehabilitation exercises, and nasogastric tube feeding were taught
to the caregivers. The second session was delivered at the time
of discharge, which included videos on emergency preparedness,
such as cardiopulmonary resuscitation, seizures, heart attack,
and hypoglycemia, while simultaneously discussing and
answering any queries the participants had after watching each
set of videos. The third session was delivered at the first month
of follow-up after discharge and included videos on frequently
used medications by stroke survivors, such as anticoagulants,
antihypertensive, and lipid-lowering drugs. The fourth session
was delivered at the third-month of follow-up after discharge
and included videos on secondary stroke prevention (recurrent
attack)—exercise, physical activity, recognition of depression,
diet modification, and accurate measurement of BP and blood
sugar levels (Figure 1).
Figure 1. Movies4Stroke collage. CPR: cardiopulmonary resuscitation.
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Control Group
Participants in the control group received the standard of care
that is provided to stroke patients at AKUH. Stroke survivors
were given instructions before discharge regarding diet, the
need for rehabilitation, possible complications, and medication
use; information booklets were also handed out. A
multidisciplinary team comprising a neurophysician, stroke
nurse, dietitian, and physiotherapist imparted the information.
Verbal instructions were given to stroke survivors and their
caregivers. On the day of discharge, or 24 hours before
discharge, a discharge coordinator provided the researchers
details about the skills learned and ensured that the medical,
social, and rehabilitation requirements were in place before
going out of the hospital. All the study participants were
provided follow-up appointments at the clinic. A detailed written
discharge summary was handed over to the caregiver, detailing
all aspects of care, including follow-up visit, medications, lab
investigations, and serious alerts. The control group compliance
to this standard of care was ensured, as all staff follow the
abovementioned discharge protocol and document education.
There is designated staff education and a safe discharge
coordinator dedicated for all admissions at this center. The
center at which this study was performed is an internationally
accredited center, and performance and documentation of these
quality of care standards are a part of the standard of care
protocol. This standard of care was followed for all participants
in the control group because of these regulations that are in
place to maintain accreditation and auditable quality of care.
The control group did not receive the additional visual teaching
of the video-based intervention. This standard of care was
followed for all participants including those who received the
video-based intervention.
Compliance During the Administration of the
Intervention
A study officer who was not blinded to the intervention group
took several measures to ensure compliance of the participants
to the videos as mentioned in the protocol [9]. There were
trained research officers to ensure compliance of the intervention
group participants at each video delivery; moreover, constant
SMS reminders were sent to the study participants in the
intervention group (as a measure of reinforcement) to watch
these thematic movies in a relaxed home environment, and they
were also reminded about their scheduled follow-up visits.
Follow-Up
Follow-up visit for each stroke survivor-caregiver dyad was
organized at 1, 3, 6, 9, and 12 months after discharge in the
neurology clinic for outcome ascertainment. Stroke survivors
and their caregivers were given a handout with instructions and
basic information about their subsequent follow-up visit.
Caregivers were also explained verbally about the importance
of their follow-up visit. They were asked to contact the study
team through the Stroke Helpline for any queries regarding their
health.
The follow-up rates were maximized by sending SMS reminders
to all the study participants about their respective follow-up
visits at least a day before their scheduled follow-up visit
through our Stroke Helpline number and by also allowing an
approximate 14-day grace period to the stroke survivor and
caregiver who were unable to report as per their scheduled
follow-up visit. Those participants who did not appear for their
scheduled follow-up visit were contacted through phone or
approached through indirect means, such as contacting them
when they came to the AKUH for any other clinic or
physiotherapy visit or lab investigations. Details of stroke
survivors’ visit to the AKUH, other than the neurology clinic,
was obtained through telecommunication with the caregiver or
tracking the stroke survivor through the synchronized electronic
medical record system of the AKUH (Figure 2).
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Figure 2. Study flow (enrollment to follow-up).
Participants’ Timeline
After recruiting stroke survivors along with their primary
caregivers from the Stroke unit at the AKUH, the participant
dyads were not expected to come in for any additional visits for
the study purpose other than the scheduled 5 follow-up visits
at the stroke clinic. Our study started enrolling participants from
January 19, 2015, and the last participant was recruited on May
15, 2015. The last follow-up was completed on June 29, 2016.
Trial Outcomes
The primary outcome measure reported was as follows: control
of 3 major risk factors—BP, blood sugar, and lipids—measured
via standardized methods in the central laboratory was
ascertained at baseline and 6 and 12 months after discharge. All
the 3 risk factors were assessed, as the proportion of participants
achieving BP control (<125/85 mm Hg), blood sugar
(glycosylated hemoglobin A1c or HbA1c<7%), and blood
cholesterol (low-density lipoprotein [LDL] level<100 mg/dL).
Of the secondary outcomes, two are discussed in this paper with
respect to Movies4Stroke trial protocol; others will be discussed
in the subsequent paper.
Stroke-Related Mortality Among Stroke Survivors
Was Ascertained at 12 Months Post Discharge
Information on mortality among stroke survivors after discharge
was ascertained through a precoded and validated verbal autopsy
scale. In addition, we correlated all mortality with hospital
records. Mortality was further categorized as per the analysis
criteria into 3 categories: stroke-related mortality, mortality
(because of nonstroke complications), and out-of-hospital
mortality.
Included
Mortality after discharge from the AKUH because of
stroke-related complications was assessed by a review of
medical records, interviews from primary caregivers of the
patients, and the verbal autopsy standard procedure.
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Censored
Mortality after discharge from the hospital because of competing
risk, that is, cause of death not related to stroke because of, for
example, head trauma, gun shot, and cancer, was assessed.
Patients who were alive after 1 year of follow-up after discharge
(censored because of lack of outcome of interest or statistical
considerations) were assessed.
Excluded
In-hospital mortality before patients were discharged from the
hospital was a result of complications arising from an index
stroke occurring before discharge into the community in a stable
state, for example, iatrogenic complications, sepsis, and
progression of index stroke during admission.
Moreover, the categorization of all these deaths was further
validated by our team of experts including stroke specialist,
epidemiologist, statisticians, and research supervisor.
Stroke Disability and Neurological Deficits Among
Stroke Survivors Was Ascertained at Baseline and 6
and 12 Months After Discharge
A total of 3 different neurological functional assessment tools
were used in this clinical trial, as each of them captures/measures
a different parameter with respect to the functional status of
stroke survivors after acute stroke:
• mRS tool is widely used by neuro physicians globally to
assess functional disability after acute stroke [10-12].
• The National Institutes of Health Stroke Scale (NIHSS)
tool is widely used by neurophysicians globally to
objectively quantify the impairment caused by stroke
[12,13].
• The Barthel Index (BI) tool is used globally by health care
providers to assess the level of dependency among stroke
survivors after an acute episode of stroke [12,14].
The abovementioned tools were used to assess the functional
status of stroke survivors at baseline and 6- and 12-month
follow-ups.
Ethics and Human Subject Protection
Written informed consent, in both English and Urdu, was
obtained from all the study participants at the time of
recruitment. The confidentiality and privacy of the participants
was maintained by deidentification of the subject information.
Only research staff was authorized entry into the hospital system
on the computers that were used for data storage. All source
documents were maintained in locked files in locked room.
Fingerprint encryption was added to all sensitive data, for
example, mobile numbers, app logs, and error logs. The Ethical
Review Committee (ERC) of Aga Khan University, Karachi
(ERC number 2890-Med-ERC-14), approved the study.
Results
Overall Trial Flow
A total of 310 stroke survivors and their caregiver dyads, ie,
620 individuals (participant dyads), were recruited over a
duration of 6 months. As this clinical trial had a fixed block
design, 155 participant dyads were randomized in each of the
intervention and control group (310 in each group). We screened
400 participant dyads to assess eligibility; of these, 50 were not
eligible, and 40 participant dyads refused to participate in the
study (30% were excluded; Figure 3). The reasons for exclusions
were mRS>4 (n=25), travel plans (n=15), and non-Karachi
residents (n=10). The reasons for refusal were mainly the lack
of ability to return for follow-up and personal interest of the
stroke survivor or caregiver to participate in the study. We were
able to complete information on 141 participant dyads in the
intervention and 137 in the control group at the end of 1-year
postdischarge follow-up. From the intervention group, 11
participant dyads were lost to follow-up at 1 year postdischarge
and 3 stroke survivors died because of in-hospital mortality
(before being discharged) resulting from inpatient complications
from the index stroke, as compared with 15 participant dyads
who were lost to follow-up and 3 who died because of
in-hospital mortality in the control group. There was one
protocol violation in the control group that was excluded from
the final analysis.
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Figure 3. Trial flow diagram. mRS: Modified Rankin Scale.
Baseline Characteristics of the Study Participants
Mean age of stroke survivors in the intervention group was 60.6
(SD 12.0) years, whereas it was 59.7 (SD 14.3) years in the
control group. The caregivers were relatively younger, with the
mean age of 38.7 (SD 11.7) years in the intervention group and
39.8 (SD 14) years in the control group. In our trial, most of the
stroke survivors were males (109/155, 70.3%, in the intervention
group vs 100/155, 65.0%, in the control group). More than
two-thirds of the stroke survivors in our study had more than 5
years of education (114/155, 73.5%, in the intervention group
vs 107/155, 69.0%, in the control group), with 40 of 155 (25.8%)
patients being employed in the intervention group and 39 of
155 (25.1%) in the control group. More than four-fifths of our
study participants were married (134/155, 86.5%) in the
intervention group as compared to the control group (124/155,
80.0%), and more than half of the stroke survivors were living
in a joint family system (93/155, 60.0%, in the intervention
group vs 107/155, 69.0%, in the control group). Median
(interquartile range) number of household members living with
stroke survivors was 6 (range: 5-8) in the intervention group as
compared with 7 (range: 5-10) in the control group. Median
household monthly income of the stroke survivors was Rs
50,000 (US $416) in both the groups. Approximately, four-fifths
of our study participants were Android mobile phone users in
the intervention group (120/155, 77.4%) as compared with
around two-third in the control group (99/155, 63.8%). Most
variables were uniformly distributed between the two groups
and not statistically significant at baseline (refer to Table 1).
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Table 1. Baseline characteristics of study participants according to their group allocation (310 participant dyads)
P valueControl group (N=155)Intervention group (N=155)Baseline characteristics
.1759.7 (14.3)60.6 (12.0)Age (years) of the patient, mean (SD)
.35Patient’s gender, n (%)
100 (65.0)109 (70.0)Male
55 (35.0)46 (30.0)Female
39.8 (14.0)38.7 (11.7)Age (years) of the caregiver, mean (SD)
.26Source of the patient, n (%)
81 (52.2)90 (58.0)Direct
74 (47.8)65 (42.0)Referral
.01Type of operating system, n (%)
30 (19.3)14 (9.0)None
104 (67.1)127 (82.0)Android
13 (8.4)6 (3.9)Windows
8 (5.2)8 (5.1)IOS
<.001Anyone at home with Android, n (%)
99 (63.8)120 (77.4)Yes
56 (36.2)35 (22.6)No
.02Desktop PC at home, n (%)
130 (83.8)143 (92.3)Yes
25 (16.2)12 (7.7)No
.22Patient education, n (%)
31 (20.0)17 (11.0)Illiterate
17 (11.0)24 (15.5)Primary education
34 (22.0)36 (23.2)Secondary education
18 (11.6)21 (13.5)Higher secondary education
55 (35.4)57 (36.8)Above intermediate
.14Patient marital status, n (%)
9 (5.8)3 (1.9)Single
124 (80.0)134 (86.5)Married
22 (14.2)18 (11.6)Widowed
.12Patient family status, n (%)
107 (69.0)93 (60.0)Joint family
48 (31.0)62 (40.0)Nuclear family
50,000 (30,000-70,000)50,000 (30,000-100,000)Monthly family income (Pakistani rupee), median (IQR)
.45Patient employment status, n (%)
39 (25.1)40 (25.8)Employed
10 (6.5)5 (3.3)Unemployed
27 (17.4)27 (17.4)Retired
50 (32.2)43 (27.7)Housewife
29 (18.7)40 (25.8)Others
.92Family land ownership (acre), n (%)
47 (30.3)47 (30.3)None
89 (57.4)92 (59.4)<1
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P valueControl group (N=155)Intervention group (N=155)Baseline characteristics
13 (8.4)10 (6.4)Between 1 and 10
6 (3.9)6 (3.9)>10
.527 (5-10)6 (5-8)Total household members, median (IQR)
.713 (3-5)4 (3-4)Length of hospital stay, median (IQR)
.98Tissue plasminogen activator, n (%)
7 (4.5)7 (4.5)Yes
148 (95.5)148 (95.5)No
Primary Outcome
Systolic Blood Pressure
At baseline, there was a uniform distribution of study
participants with the two categories of systolic BP (<125 mm
Hg and >125 mm Hg) in the intervention group and the control
group (49/155, 50.0%, vs 48/155, 50.0%). At the 6-month visit,
the distribution of study participants with a systolic BP of <125
mm Hg was similar in the intervention group and control group
(36/109, 50.0% vs 36/99, 50.0%; risk ratio [RR] 0.91, 95% CI
0.62-1.32). At the final follow-up visit (at 12 months), there
was a greater percentage of participants with a systolic BP of
<125 mm Hg in the intervention group than in the control group
(18/54, 62.0% vs 11/52, 38.0%; RR 1.58, 95% CI 0.83-2.98).
However, none of these results were statistically significant
(refer to Table 2).
Table 2. Systolic blood pressure.
P value (overall)Risk ratio (95% CI)Control group, n (%)Intervention group, n (%)Systolic blood pressure (mm Hg)
.96Baseline results (N=310)a
1.00 (0.72-1.40)48 (50.0)49 (50.0)<125
1.00 (0.72-1.40)107 (50.0)106 (50.0)>125
.616-month results (N=208)b
0.91 (0.62-1.32)36 (50.0)36 (50.0)<125
0.91 (0.62-1.32)63 (46.0)73 (54.0)>125
.1612-month results (N=106)c
1.58 (0.83-2.98)11 (38.0)18 (62.0)<125
1.58 (0.83-2.98)41 (53.0)36 (47.0)>125
aBaseline: intervention group (n=155) and control group (n=155).
b6-month results: intervention group (n=109) and control group (n=99).
c12-month results: intervention group (n=54) and control group (n=52).
Diastolic Blood Pressure
At baseline, there were slightly more participants with a diastolic
BP of <85 mm Hg in the intervention group than in the control
group (109/155, 51.0% vs 106/155, 49.0%). At 6 months, there
was a greater percentage of stroke survivors with a diastolic BP
of <85 mm Hg in the intervention group than in the control
group (82/109, 55.0% vs 68/99, 45.0%; RR 1.10, 95% CI
0.92-1.30). Similar to this, at the final visit at 12 months, there
was a greater percentage of participants with a diastolic BP of
<85 mm Hg in the intervention group than in the control group
(44/54, 55.0% vs 37/52, 45.0%; RR 1.15, 95% CI 0.92-1.42).
These results failed to reach a statistically significant level (refer
to Table 3).
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Table 3. Diastolic blood pressure.
P value (overall)Risk ratio (95% CI)Control group, n (%)Intervention group, n (%)Diastolic blood pressure (mmHg)
.84Baseline results (N=310)a
1.02 (0.88-1.18)106 (49.0)109 (51.0)<85
1.02 (0.88-1.18)49 (51.0)46 (49.0)>85
.296-month results (N=208)b
1.10 (0.92-1.30)68 (45.0)82 (55.0)<85
1.10 (0.92-1.30)31 (54.0)27 (46.0)>85
.2112-month results (N=106)c
1.15 (0.92-1.42)37 (45.0)44 (55.0)<85
1.15 (0.92-1.42)15 (60.0)10 (40.0)>85
aBaseline: intervention group (n=155) and control group (n=155).
b6-month results: intervention group (n=109) and control group (n=99).
c12-month results: intervention group (n=54) and control group (n=52).
Glycosylated Hemoglobin A1c
At baseline, there was a smaller percentage of participants with
an HbA1c level <7% in the intervention group than in the control
group (88/155, 45.0% vs 105/155, 55.0%). At the 6-month visit,
there was a slightly higher percentage of stroke survivors with
a HbA1c level <7% in the intervention group than in the control
group, (81/105, 52.0% vs 74/91, 48.0%; RR 0.95, 95% CI
0.82-1.10). Similarly, at the final visit at 12 months, there was
a greater percentage of participants with an HbA1c level <7%
in the intervention group than in the control group (36/55, 55.0%
vs 30/40, 45.0%; RR 0.87, with 95% CI 0.66-1.14). However,
these results failed to demonstrate statistical significance (refer
to Table 4).
Table 4. Glycosylated hemoglobin A1c.
P value (overall)Risk ratio (95% CI)Control group, n (%)Intervention group, n (%)Glycosylated hemoglobin A1c (%)
.03Baseline results (N=310)a
0.81 (0.68-0.98)105 (55.0)85 (45.0)<7
0.81 (0.68-0.98)50 (42.0)70 (58.0)>7
.476-month results (N=196)b
0.95 (0.82-1.10)74 (48.0)81 (52.0)<7
0.95 (0.82-1.10)17 (42.0)24 (58.0)>7
.3212-month results (N=95)c
0.87 (0.66-1.14)30 (45.0.0)36 (55.0)<7
0.87 (0.66-1.14)10 (35.0)19 (65.0)>7
aBaseline: intervention group (n=155) and control group (n=155).
b6-month results: intervention group (n=105) and control group (n=91).
c12-month results: intervention group (n=55) and control group (n=40).
Low-Density Lipoprotein
At baseline, there was a greater percentage of study participants
with an LDL level<100 mg/dL in the intervention group than
in the control group (92/155, 59.0% vs 64/155, 41.0%). A
similar trend was seen at the third follow-up visit: There was a
higher percentage of stroke survivors with an LDL level<100
mg/dL in the intervention group than in the control group
(73/106, 57.0% vs 56/90, 43.0%; RR 1.10, 95% CI 0.90-1.36).
Again, a very similar trend was seen at the fifth follow-up visit:
There was a greater percentage of participants with an LDL
level <100 mg/dL in the intervention group than in the control
group (36/51, 55.0%, vs 30/45, 45.0%; RR 1.06, 95% CI
0.81-1.39). However, these results failed to demonstrate
statistical significance (refer to Table 5).
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Table 5. Low-density lipoprotein.
P value (overall)Risk ratio (95% CI)Control group, n (%)Intervention group, n (%)Low-density lipoprotein (mg/dL)
<.001Baseline results (N=310)a
1.42 (1.13-1.78)64 (41.0)92 (59.0)<100
1.42 (1.13-1.78)91 (59.0)63 (41.0)>100
.336-month results (N=196)b
1.10 (0.90-1.36)56 (43.0)73 (57.0)<100
1.10 (0.90-1.36)34 (51.0)33 (49.0)>100
.6812-month results (N=96)c
1.06 (0.81-1.39)30 (45.0)36 (55.0)<100
1.06 (0.81-1.39)15 (50.0)15 (50.0)>100
aBaseline: intervention group (n=155) and control group (n=155).
b6-month results: intervention group (n=106) and control group (n=90).
c12-month results: intervention group (n=51) and control group (n=45).
Secondary Outcomes
Mortality and the Number Needed to Treat
Overall, 35 deaths were reported over the course of 1-year
follow-up in the Movies4Stroke trial (Multimedia Appendix 1).
Mortality among stroke survivors because of stroke-related
complications (included group) was higher in the control group
than in the intervention group (13/155, 8.4% vs 2/155, 1.3%).
The most common cause of mortality was aspiration pneumonia.
Censored deaths in both the groups were caused by
non–stroke-related complications and were therefore not
considered a part of the included group. The results were found
to be highly significant (P<.001). Absolute risk reduction (ARR)
of mortality related to stroke-related complications was 7%,
which yielded a number needed to treat (NNT) of 15. It meant
that we needed to show the video-based intervention to 15 stroke
survivors to prevent 1 death from stroke-related complications
(refer to Table 6 and Figure 4).
Table 6. Categorization of mortality, ARR, and NNT.
P valueNumber needed to treatAbsolute risk reductionControl group
(N=155), n (%)
Intervention group
(N=155), n (%)
Mortality categorized
N/AN/AN/Aa135 (87.1)140 (90.3)Patient is alive
<.00115b7.113 (8.4)2 (1.3)Included
N/AN/AN/A4 (2.6)10 (6.5)Censored
N/AN/AN/A3 (1.9)3 (1.9)Excluded
aNot applicable.
bNumber needed to treat of 15 has been rounded off to a whole number.
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Figure 4. The Kaplan-Meier survival estimates in the first year after stroke in the intervention versus control group because of stroke-related avoidable
mortality.
Change in Functional Status (Disability and Severity)
Among Stroke Survivors
Modified Rankin Scale
Table 7 and Figures 5 and 6 show that at baseline, as assessed
by mRS, a higher percentage of stroke survivors with moderate
to severe disability were present in the intervention group than
in the control group (46/155, 29.7% vs 36/155, 23.2%; odds
ratio [OR] 1.18, 95% CI 0.58-2.39). Similarly, at 6 months, a
higher percentage of stroke survivors with moderate to severe
disability were present in the intervention group than in the
control group (24/135, 17.8% vs 18/129, 14.0%; OR 1.28, 95%
CI 0.65-2.55). However, at 12 months, a higher percentage of
stroke survivors had minimal to no disability in the intervention
group than in the control group (91/128, 71.1% vs 71/120,
59.2%). At 12 months postdischarge, NNT was 9, as assessed
by the mRS. This meant that we needed to show Movies4Stroke
to 9 stroke survivors to achieve minimal to no disability caused
by stroke after a year of follow-up.
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Table 7. Modified Rankin Scale.
P value (overall)Odds ratio (95% CI)Control group, n (%)Intervention group, n (%)Modified Rankin Scale score
.40Baseline results (N=310)a
Reference25 (16.1)25 (16.1)0-1
0.82 (0.44-1.55)94 (60.7)84 (54.2)2-3
1.18 (0.58-2.39)36 (23.2)46 (29.7)4-5
.406-month results (N=264)b
Reference79 (61.2)82 (60.7)0-1
0.99 (0.55-1.83)28 (21.7)29 (21.5)2-3
1.28 (0.65-2.55)18 (14.0)24 (17.8)4-5
—
c4 (3.1)0 (0.0)Death
.0712-month results (N=248)d
Reference71 (59.2)91 (71.1)0-1
0.47 (0.24-0.91)30 (25.0)18 (14.1)2-3
0.78 (0.38-1.58)19 (15.8)19 (14.8)4-5
aBaseline: intervention group (n=155) and control group (n=155).
b6-month results: intervention group (n=135) and control group (n=129).
cOdds ratio with their 95% CI could not be estimated because of the empty cell count in the intervention group.
d12-month results: intervention group (n=128) and control group (n=120).
Figure 5. Functional status of stroke survivors—6 months. NIHSS: National Institutes of Health Stroke Scale.
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Figure 6. Functional status of stroke survivors—baseline and 12 months assessment (comparison).
National Institutes of Health Stroke Scale
Table 8 and Figures 5 and 6 show that at baseline, as assessed
by the NIHSS, a higher percentage of stroke survivors had
severe impairment caused by stroke in the control group than
in the intervention group (72/155, 46.4% vs 61/155, 39.4%; OR
0.82, 95% CI 0.39-1.74). At 6 months, a smaller percentage of
stroke survivors had severe impairment caused by stroke in the
intervention group than in the control group (23/135, 17.0% vs
25/129, 19.4%; OR 0.98, 95% CI 0.50-1.92). At 12 months, a
higher percentage of stroke survivors had minimal to no
impairment caused by stroke in the intervention group than in
the control group (65/128, 50.8% vs 55/120, 45.8%). At 12
months postdischarge, NNT was 20 as per the NIHSS
assessment. This meant that we needed to show Movies4Stroke
to 20 stroke survivors to have minimal to no disability caused
by stroke after a year of follow-up.
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Table 8. National Institutes of Health Stroke Scale.
P value
(overall)
Odds ratio (95% CI)Control group, n (%)Intervention group, n (%)National Institutes of Health
Stroke Scale score
.52Baseline results (N=310)a
Reference17 (11.0)18 (11.6)0-1
1.09 (0.51-2.28)66 (42.6)76 (49.0)2-8
0.82 (0.39-1.74)72 (46.4)61 (39.4)>9
.086-month results (N=264)b
Reference62 (48.0)58 (43.0)0-1
1.52 (0.88-2.63)38 (29.5)54 (40.0)2-8
0.98 (0.50-1.92)25 (19.4)23 (17.0)>9
—
c4 (3.1)0 (0.0)Death
.7312-month results (N=248)d
Reference55 (45.8)65 (50.8)0-1
0.81 (0.46-1.41)44 (36.7)42 (32.8)2-8
0.85 (0.42-1.71)21 (17.5)21 (16.4)>9
aBaseline: intervention group (n=155) and control group (n=155).
b6-month results: intervention group (n=135) and control group (n=129).
cOdds ratio with their 95% CI could not be estimated because of the empty cell count in the intervention group.
d12-month results: intervention group (n=128) and control group (n=120).
Barthel Index
Table 9 and Figures 5 and 6 show that at baseline, as assessed
by the BI, an equal percentage of stroke survivors had total to
severe dependency in the intervention group as compared with
the control group (78/155, 50.3% vs 78/155, 50.3%; OR 1.08,
95% CI 0.63-1.86). At 6 months, a smaller percentage of stroke
survivors had total to severe dependency in the intervention
group than in the control group (22/135, 16.3% vs 23/129,
17.8%; OR 0.93, 95% CI 0.48-1.81). At 12 months, a higher
percentage of stroke survivors with minimal to no dependency
were present in the intervention group than in the control group
(87/128, 68.0% vs 71/120, 59.2%). At 12 months postdischarge,
NNT was 12, as per the BI assessment.
As evident in Figure 7 and according to the mRS, when
comparing the baseline with the 12-month follow-up visit, more
survivors in the intervention group had seen the videos and had
minimal to no disability at the end of the 12 months as compared
with the control group. Similarly, according to NIHSS, when
comparing baseline with 12-month follow-up visits, there was
a higher percentage of survivors with minimal neurologic deficit
at 12 months in the intervention group as compared with the
control group. Similarly, for BI, when comparing baseline with
12-month follow-up visits, there was a higher percentage of
survivors with had minimal to no dependency at 12 months in
the intervention group as compared with the control group.
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Table 9. Barthel Index.
P value (overall)Odds ratio (95% CI)Control group, n (%)Intervention group, n (%)Barthel Index score
.94Baseline results (N=310)a
Reference40 (25.8)38 (24.5)95-100
1.11 (0.59-2.09)37 (23.9)39 (25.2)55-90
1.08 (0.63-1.86)78 (50.3)78 (50.3)0-50
.166-month results (N=264)b
Reference73 (56.6)75 (55.6)95-100
1.28 (0.71-2.28)29 (22.5)38 (28.1)55-90
0.93 (0.48-1.81)23 (17.8)22 (16.3)0-50
—
c4 (3.1)0 (0.0)Death
.3512-month results (N=248)d
Reference71 (59.2)87 (68.0)95-100
0.70 (0.37-1.32)27 (22.5)23 (18.0)55-90
0.67 (0.33-1.34)22 (18.3)18 (14.0)0-50
aBaseline: intervention group (n=155) and control group (n=155).
b6-month results: intervention group (n=135) and control group (n=129).
cOdds ratio with their 95% CI could not be estimated because of the empty cell count in the intervention group.
d12-month results: intervention group (n=128) and control group (n=120).
Figure 7. Functional status of stroke survivors—baseline and 12 months assessment (comparison).
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Discussion
Principal Findings and Their Contextual Relevance
Movies4Stroke is a randomized controlled mHealth trial
evaluating the effectiveness and safety of a phone-based
intervention that showed thematically designed videos to assist
the stroke survivor and caregiver dyad to get the knowledge,
skills, and confidence needed to improve poststroke risk factor
control, survival, and functional outcomes. The rationale of this
trial was to provide repetitive high-quality survival and training
to stroke survivor and caregiver dyads returning to a low- to
middle-income community where rehabilitation and chronic
care systems are underdeveloped. The mode of video-based IT
intervention, along with competency and understanding checks
and the ability to repeat and see a video, was used to assist the
understanding in a literacy-challenged population that, however,
had access to a cell phone. None of the trial participants were
excluded because of the lack of a cell phone. This mHealth trial
failed to reach its primary outcome measure of the control of
hypertension, LDL cholesterol, and HbA1c; however, the
prespecified secondary variables of improved functional
outcomes and reduced mortality were improved in the
intervention group in this study because of stroke-related
complications. This study demonstrated that showing the video
to a literacy-challenged population in a country without any
chronic care health facility saved lives. The NNT was only 15,
to save 1 life, because of avoidable stroke-related complications
and death. This trial provides early data on nonpharmacological
intervention in stroke survivors. There are few interventions of
this nature identified in a recent meta-analysis and review and
none that employs mHealth in a complex, challenging, and
resource-strapped setting (refer to Multimedia Appendix 2)
[15-21].
Primary and Secondary Outcome Results: Mechanistic
Explanations
Movies4Stroke failed to achieve its primary outcome variable
of the control of primary risk variables of hypertension, LDL
cholesterol, or HbA1c in the intervention. There could be several
reasons for these findings. First, the baseline adherence in this
population was already substantially better than the general
population, possibly because of the seriousness of stroke and
exposure to specialist care and counseling techniques; thus, it
became difficult to further improve adherence and the related
improvement in risk factors. This could be explained by the
Health Belief Model demonstrating that better outcomes are
found in patients who understand the severity of their disease
and the benefits that changing their actions would yield [22,23].
Second, in this study, to maintain long-term follow-up, the
control group also had access to a 24/7 helpline, and interaction
with health care personnel who assisted and resolved queries
may have improved behavior in this group as well. The presence
of a centralized helpline has shown to help address queries and
patients cope with difficult situations [24].
Third, this was a sequential and thematic intervention where
these 5-min video lessons were rolled out in order of what skill
would be important for survival in the early stages as compared
with the later stages of stroke. Hence at admission, the survivor
and caregiver dyad were provided with skills and training to
recognize life-threatening emergencies and respond to them
accordingly. At the time of discharge, each dyad was taught
rehabilitation and safe swallowing. Thematic movies on
adherence and medication safety module were taught in the first
month; thus, these preventive aspects were dealt with much
later, and this might in itself be associated with learning fatigue,
or perhaps, these movies were taught by the time the risk factor
control had already maximized in the participants in the study.
Finally, it is difficult to design measures that capture pill
compliance in the stroke population; stroke patients have diverse
prescriptions that vary in the type of drug classes, number, and
frequency of dosage, and no single biomarker would be
applicable to all the study participants nor could electronic pill
boxes capture the actual drug usage to achieve BP, glucose, or
cholesterol control, as they record the number of times a box is
opened. Moreover, it cannot be assumed that the participants
have consumed all the pills for that dose when they open a box.
However, we can see that the harder outcome measure of the
control of BP, cholesterol, or blood sugar was not achieved.
In addition, these negative findings on risk factor control shed
light on the importance of health theory and behavioral science
designing an intervention, rather than considering just simple
knowledge transfer while designing an intervention. This
resonates with previous studies concluding that to achieve
effective change in health systems and patient care, knowledge
transfer alone is insufficient and has to be supplemented with
other forms of intervention [25]. In a single-center study [26],
showing just one video in an in-patient setting increased
knowledge; however, it did not translate into BP monitoring in
a home environment or increase physician follow-up visits. The
sustained intervention in our study revealed that, at least the
skills to prevent complications might have been acquired.
Nonadherence to medication has two components—intentional
and unintentional nonadherence [27]. Intentional nonadherence
refers to nonadherence that is deliberate and may be because of
motivational factors that may be directly related to the perceived
efficacy of the medicine, distrust, and the lack of knowledge,
whereas unintentional nonadherence is nonadherence that is
largely related to either forgetting or the lack of capacity to take
the medicine. In our study, we focused on improving knowledge,
empowerment, and self-efficacy, but we did not send repeated
reminders to improve unintentional nonadherence. Similar
results were obtained in a study implemented in Sydney,
Australia, focusing on participants with coronary heart disease
in which repeated lifestyle modification messages/reminders
showed significant results with respect to harder outcomes such
BP and cholesterol [28]. This highlights the importance of
mHealth design to be multifaceted and used as a platform for
re-enforcement to address behavior change with regard to
adherence. It also highlights the potential of mHealth to be
harnessed in reducing the burden of NCDs when interventions
are designed using health theory, and they can inform
effectiveness, thus achieving the millennium development goals
[29,30].
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Interestingly, each of our prespecified secondary outcome
variables improved in this study. Secondary outcomes of
Movies4Stroke trial aimed at improving functional outcomes
and reducing mortality because of stroke-related complications,
and the results are very promising, given the difficult context
of the intervention. The mortality analysis showed that in the
control group, there were 9 of 13 cases of massive aspiration
pneumonias that resulted in mortality, which could have been
avoided by aspiration precautions and learning tube feeding
safety measures. In addition, recognizing aspiration and
reporting early could have resulted in saving lives. There were
2 mortalities in the intervention group, one because of a massive
recurrent stroke and the other because of aspiration. The other
mortalities were not related directly to stroke-mediated
complications. Given the limited nature of these observations,
these findings are worthy of attention but need to be confirmed
in larger cohorts with prolonged follow-up periods.
Skills to help identify, prevent, and respond to poststroke
complications were taught through 5-min videos that had been
rolled out in an orderly manner, with preventable early
complications addressed first, followed by late complications.
This method of interactive, repeated teaching increased the skill
and confidence of the caregivers and thus resulted in saving
lives and improving the functional outcomes and reducing
disability.
Other studies have similarly reported that timely recognition
and reporting of complications resulted in low mortality and
improved outcomes among stroke survivors [31,32]. Through
these movies, knowledge transfer helped change the skills of
the caregivers rather than the adherence of stroke survivors.
Along with this, Movies4Stroke might have influenced health
beliefs of stroke survivors and their caregivers by helping them
understand their increased susceptibility and therefore the
importance of prompt action to prevent death because of
complications [33,34]. Moreover, Movies4Stroke also had
videos aimed at providing psychoeducational intervention and
support through the helpline to the caregivers along with the
procedural knowledge. These three components have been
pivotal in helping prevent stress and strain in informal caregivers
[19], which may also explain the active involvement and
effective skill knowledge of caregivers in this study.
Owing to the varying definitions of successful stroke recovery,
it is difficult to find a standard measure of recovery, which is
why we used three different scales [35]. The improvement
observed in functional outcomes in the intervention group might
have been because of the learning model that these videos were
based upon. Rehabilitation measures and approaches were
described and taught in the videos. However, the demonstration
of each, by registered professional physiotherapists, nurses,
stroke survivors with significant disability, and speech and
swallowing experts, helped augment the learning process and
made it easy for patients and their caregivers to mimic and
follow each step taught effectively. One of the most important
aspects of these movies was watching real stroke survivors
perform the exercises themselves; it acted as a morale booster
and further encouraged participants to continue with the
exercises. The added feature of being able to replay and rewatch
these videos might have been another factor that aided their
learning process, resulting in significant improvement in
functional status.
These results are encouraging in several ways. First, as the
extent of improvement in the functionality of stroke survivors
demonstrates the ability to return to an improved functionality
level with the help of only these movies and their primary
caregivers without the need of a skilled nurse or a standard
rehabilitation center. This is similar to the results of a trial that
compared and concluded equivalent improvements in patients
who received home-based rehabilitation therapy with a caregiver
and others who received therapy with a professional therapist,
thereby establishing home-based rehabilitation as equally
effective, as shown with Movies4Stroke [36]. These video
lessons filled the niche that the lack of these interventions might
have created and bridged the gap between learning and
implementation process [37]. Although there have been several
discussions calling for attention to NCDs at national and
international level to help meet the MDGs, there has also been
concern regarding the high costs of treatment and recurrence
of debilitating events such as cardiovascular death. These have
prompted debate among the policy makers to establish ways
for primary prevention, affordable treatment measures, and
monitoring of NCDs [38,39]. Movies4Stroke is a step in this
direction, aimed at providing better health care, and prevention
through diet and healthy activity, thus curbing the alarming
burden of NCDs in LMICs
Trial Strengths
The major strengths of this trial were the use of a randomized
controlled trial design at a center where an internationally
certified care model is followed with an algorithmic approach;
hence, the results generated can be attributed to the effect of
intervention.
The risk of bias was minimized by paying attention to domains
that defined trial quality [19,40,41]. Selection bias was reduced
by random centralized computer-based sequence generation;
allocation was concealed by opaque sequentially numbered
envelopes that were dispatched by CTU, which included
university-based staff, which was separate from the research
team. Performance and detection bias was reduced by blinded
outcome assessment and cross-checks of contamination during
the course of the trial and uniform training of staff on study.
Attrition bias was addressed by multiple means of
follow-up—maintaining good level of understanding with the
participants, sending SMS reminder for follow-ups, and
preserving communication through Stroke Helpline number.
We were successful in keeping an overall dropout rate of less
than 9%, with sensitivity analysis showing that were no
significant differences between the characteristics of
dropouts/those lost to follow-up and those who continued the
study in both the groups (Multimedia Appendix 3). Reporting
bias was reduced by reporting all possible outcomes of interest
as defined in the protocol. Intention-to-treat analysis has been
used to report outcomes.
To ensure compliance to the intervention, the first time, the
videos were viewed in the presence of a research officer, and
intervention was delivered at 100% rate, with complete
verbalized understanding and unhurried visualization. To track
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usage patterns at home, we remotely monitored the access and
use of our app that had been installed in the mobile phone. Early
results show that the rehabilitation and tube feeding videos were
the highly accessed videos at home. These analyses are still
ongoing.
Trial Limitations
The major limitation of our clinical trial is that it is a
single-center study, chosen because of the fact that this site
provided a standard of care that is algorithmic and replicable;
thus, results generated can be attributed to the effect of
intervention. In this study, we reported its efficacy, but the
performance and potential effect size in different sites may be
variable and potentially be more effective, given the usual care
standards in even more resource-strapped comparative health
systems, for example, the government sector, and thus, external
validity is limited. Furthermore, those with more severe stroke
or better health access because of socioeconomic status are more
likely to visit the health systems and volunteer to participate in
an educational training intervention, thus limiting direct external
validity. We would definitely include nonresponse analysis in
futures studies to further identify characteristics of those most
likely to adopt the intervention. Another significant limitation
is of contamination bias in an educational intervention. Care
was taken to avoid contamination of the nonintervention group
with the intervention. To ensure this, videos were shown in a
separate room and not at the bedside. Given the fact that families
share information, contamination was possible; however, most
stroke survivors were on different schedules for follow-up visits
and rehabilitation times, and so, we expected less contamination
than in areas where a lot of time is spent together by families.
Obviously, it is an inherent limitation of an educational
intervention that blinding of participants is not possible. This
intervention in a study setting required human resources in terms
of a study officer and IT back up, development required human
resource, and deployment required at least three staff in a study
setting. To predict feasibility, we need to further analyze
cost-effectiveness and realistic compliance in a clinical setting
with the current patient volumes, so this limits directly
recommending applicability. This study has collected data on
cost-effectiveness, which is under analysis at this time.
Way Forward
In conclusion, we demonstrate the potential of mHealth
interventions to save lives and reduce disability in low- to
middle-income country settings; we also show that these
interventions are safe and feasible, despite their complexity.
Our results demonstrate the key importance of health theory in
designing these complex health interventions for replicability
and informing further interventions. Interventions that target
compliance must have repetitive reminders for nonintentional
adherence, and those that target knowledge and skills transfer
must have the capacity to repeat and bolster confidence as well
as provide the user the opportunity to model themselves from
the materials taught, despite the lack of literacy skills to be safe.
Complex interventions targeting these settings need to have a
design theory in place to deliver both these aspects to be
effective.
Please refer to Consolidated Standards of Reporting
Trials-eHealth checklist for details regarding this Movies4Stroke
trial [42].
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